TIXiMED
Birmingham, US · Founded 2021 · Delaware corporation
Find your way into TIXiMED
Sign up to see every warm intro you have to TIXiMED
- Paths you didn't know you had: your email and LinkedIn already hold routes to the TIXiMED team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
TM
Thomas Michael Goodrich IIExecutive
Board
AS
Aneth ShalevBoard director
Reported raises · per SEC filings
Form D private placements$550K disclosed across 1 of 2 rounds · 2024–2026
▶$550KraisedNov 2024 · 3 investors · PharmaceuticalsRule 506(b)
▶$550KraisedNov 2024 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Thomas Michael Goodrich IIExecutive Officer, Director
- Aneth ShalevDirector
- Offering amount
- $550K
- Amount sold
- $550K
- First sale
- Oct 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has TIXiMED raised?
- TIXiMED has disclosed $550K raised across 1 of its 2 known rounds.
- Where is TIXiMED headquartered?
- TIXiMED is headquartered in Birmingham, US.